Fulgent Genetics (FLGT) closed at $24.85 on November 12, 2026, down 3.3% from the previous close, on volume of 269,209 shares (30-day average 342,681).
Data as of November 12, 2026.
12-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 9, 2026 | Call with Delta Hedge | 16-Apr-27 30 C +32,000 Stock | 850 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
Fulgent Reports Third Quarter 2026 Financial Results
Business Wire (Thu, 5-Nov 4:05 PM ET)
Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Business Wire (Thu, 15-Oct 4:05 PM ET)
Fulgent’s Q1 2026: Repurchase Program Drives Balance Sheet Strength Amid Continued Losses
Market Chameleon (Fri, 1-May 5:45 AM ET)
Market Chameleon (Fri, 27-Feb 3:19 AM ET)
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Fulgent Genetics trades on the NASDAQ stock market under the symbol FLGT.
As of November 12, 2026, FLGT stock price declined to $24.85 with 269,209 million shares trading.
FLGT has a beta of 0.11, meaning it tends to be less sensitive to market movements. FLGT has a correlation of 0.00 to the broad based SPY ETF.
FLGT has a market cap of $694.28 million. This is considered a Small Cap stock.
Last quarter Fulgent Genetics reported $90 million in Revenue and -$.09 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.63.
In the last 3 years, FLGT traded as high as $31.04 and as low as $13.46.
The top ETF exchange traded funds that FLGT belongs to (by Net Assets): VTI, IWM, DFAS, IWN, VXF.
FLGT has underperformed the market in the last year with a return of -14.5%, while SPY returned +11.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in FLGT shares. However, FLGT has outperformed the market in the last 3 month and 2 week periods, returning +32.8% and +14.6%, while SPY returned -1.7% and -1.6%, respectively. This indicates FLGT has been having a stronger performance recently.
FLGT support price is $24.80 and resistance is $26.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FLGT shares will trade within this expected range on the day.
